BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34887166)

  • 1. Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal adenocarcinoma.
    Chen H; Xu Z; Shen Z; Weng Y; Wang W; Ying X; Wang X; Deng X; Shen B
    Eur J Surg Oncol; 2022 May; 48(5):1062-1067. PubMed ID: 34887166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma.
    Schmidt CM; Matos JM; Bentrem DJ; Talamonti MS; Lillemoe KD; Bilimoria KY
    J Gastrointest Surg; 2008 Dec; 12(12):2078-86. PubMed ID: 18836784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
    Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
    Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis.
    Yoon MS; Lee HS; Kang CM; Lee WJ; Keum J; Sung MJ; Kim SS; Park MS; Jo JH; Chung MJ; Park JY; Park SW; Song SY; Hwang HK; Bang S
    Gut Liver; 2022 Jan; 16(1):118-128. PubMed ID: 34140428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinar cell carcinoma: a report of 19 cases with a brief review of the literature.
    Wang Y; Wang S; Zhou X; Zhou H; Cui Y; Li Q; Zhang L
    World J Surg Oncol; 2016 Jun; 14(1):172. PubMed ID: 27352960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
    Seo S; Yoo C; Kim KP; Ryoo BY; Chang HM; Hong SM; Lee JH; Song KB; Hwang DW; Kim KH; Hwang S; Kim SC
    J Dig Dis; 2017 Aug; 18(8):480-486. PubMed ID: 28671770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
    Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
    BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A propensity score-matched retrospective cohort study.
    Weng Y; Shen Z; Gemenetzis G; Jin J; Chen H; Deng X; Peng C; Shen B
    Int J Surg; 2022 Aug; 104():106801. PubMed ID: 35934284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenectomies (OPD): a propensity score-weighted survival analysis.
    Mejia A; Shah J; Vivian E; Beard R; Acharya P; Gutierrez JCB
    J Robot Surg; 2023 Jun; 17(3):1085-1096. PubMed ID: 36581740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection.
    Chen H; Li F; Zou S; Xie J; Zhang J; Deng X; Chen H; Shen B
    World J Surg Oncol; 2021 Jun; 19(1):166. PubMed ID: 34107980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis.
    Kim JK; DePeralta DK; Ogami T; Denbo JW; Pimiento J; Hodul PJ; Malafa MP; Kim DW; Fleming JB; Powers BD
    J Surg Oncol; 2020 Nov; 122(6):1074-1083. PubMed ID: 32673436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score matching study.
    Chen K; Tong Q; Yan JF; Huang CJ; Pan Y; Zhang RC; Chen QL; Zheng XY; Cai XY; Wang Y; Wang XF
    Updates Surg; 2020 Jun; 72(2):387-397. PubMed ID: 32266660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive (subtotal) distal pancreatectomy for pancreatic ductal adenocarcinoma: a propensity score matched cohort study of short- and long-term outcomes compared with those of conventional distal pancreatectomy.
    Watanabe Y; Nakata K; Mori Y; Ideno N; Ikenaga N; Ohtsuka T; Nakamura M
    Langenbecks Arch Surg; 2022 Jun; 407(4):1479-1488. PubMed ID: 35146547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.